Intramuscular capillary-type hemangioma: Diagnosis, treatment, and outcomes. A French multicentric retrospective study of 66 cases.

Extracranial arteriovenous malformation Hemangioma of the skeletal muscle Intramuscular capillary-type hemangioma Intramuscular fast-flow vascular anomaly Intramuscular hemangioma Intramuscular vascular malformation

Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 09 03 2023
revised: 02 07 2023
accepted: 03 07 2023
medline: 24 7 2023
pubmed: 10 7 2023
entrez: 9 7 2023
Statut: ppublish

Résumé

Intramuscular capillary-type hemangiomas (ICTHs) are rare entities, belonging to the group of intramuscular "hemangiomas." The diagnosis remains challenging. We aimed to assess the diagnostic criteria, treatments and outcomes of ICTHs. This retrospective study collected all cases of ICTH followed up in 9 French hospital centers, reviewed by an adjudication expert group. Among 133 patients screened, 66 with ICTH were included. The median age of patients at diagnosis was 28.0 years, interquartile range (21.0---36.0). The lesion, mainly presenting as a gradually increasing mass (83.9%), was painless (88.9%) and was located in the head and neck (42.4%). MRI (available in all cases) mainly revealed a well-delineated lesion, isointense to the muscle on T1-weighted images, with enhancement after contrast injection; hyperintense on T2-weighted images; and containing flow voids. Among the 66 cases, 59 exhibited typical ICTH features and 7 shared some imaging features with arteriovenous malformations. These latter were larger than typical ICTHs and more painful and appeared on imaging as less well delimited and more heterogeneous tissue masses, with larger tortuous afferent arteries, earlier draining vein opacification and mild arteriovenous shunting. We propose to name these lesions arteriovenous malformation (AVM)-like ICTH. Pathological reports were similar in typical and AVM-like ICTH, showing capillary proliferation with mainly small-size vessels, negative for GLUT-1 and positive for ERG, AML, CD31 and CD34, with low Ki67 proliferation index (<10%), and adipose tissue. The most frequent treatment for ICTH was complete surgical resection (17/47, 36.2%), preceded in some cases by embolization, which led to complete remission. ICTH can be diagnosed on MRI when it is typical. Biopsy or angiography are required for atypical forms.

Identifiants

pubmed: 37423018
pii: S0720-048X(23)00276-0
doi: 10.1016/j.ejrad.2023.110962
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110962

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jordan Orly (J)

CHRU Tours, Department of Dermatology, Unit of Pediatric Dermatology, Tours, France; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Tours), Tours, France.

Annouk Bisdorff (A)

Reference Center for Vascular Anomalies FAVA-multi, University Hospital of Lariboisière, Coordinator of the Constitutive Center for Superficial Arteriovenous Malformations in Children and Adults, AP-HP, Department of Neuroradiology, Paris, France.

Antoine Fraissenon (A)

Service d'Imagerie, Consultation Multidisciplinaire des Angiomes, Centre de Compétence National Malformations Vasculaires Superficielles, Hôpital Femme Mère Enfant, Université Claude Bernard Lyon 1, Lyon-Bron, France; Service de Radiologie Mère-Enfant, Hôpital Nord, Saint-Etienne, France; CREATIS, UMR 5220, U1294 Lyon, France.

Aline Joly (A)

Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Tours), Tours, France; CHRU Tours, Department of Maxillo-facial Surgery, Tours, France.

Grégoire Boulouis (G)

Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Tours), Tours, France; CHRU Tours, Department of Neuroradiology and Interventional Radiology, Tours, France.

Laurent Guibaud (L)

Service d'Imagerie, Consultation Multidisciplinaire des Angiomes, Centre de Compétence National Malformations Vasculaires Superficielles, Hôpital Femme Mère Enfant, Université Claude Bernard Lyon 1, Lyon-Bron, France.

Elsa Tavernier (E)

University of Tours, University of Nantes, INSERM 1246-SPHERE, Tours, France; CHRU Tours, Clinical Investigation Center INSERM 1415, Tours, France.

Stéphanie Mallet (S)

University Hospital Center of Marseille, Department of Dermatology, Marseille, France.

Clément Marcelin (C)

University Hospital Center of Bordeaux, Department of Radiology, Bordeaux, France.

Juliette Miquel (J)

University Hospital Center of La Réunion, Department of Pediatric Dermatology, Saint-Pierre, La Réunion, France.

Ludovic Martin (L)

University Hospital Center of Angers, Department of Dermatology, Angers, France.

Catherine Droitcourt (C)

University Hospital Center of Rennes, Department of Dermatology, Rennes, France.

Laurence Gusdorf (L)

University Hospital Center of Reims, Department of Dermatology, Reims, France.

Claire Abasq (C)

University Hospital Center of Brest, Department of Dermatology, Brest, France.

Ali Dadban (A)

University Hospital Center of Amiens, Department of Dermatology, Amiens, France.

Christine Chiaverini (C)

University Hospital Center of Nice, Department of Dermatology, Nice, France.

Pierre Vabres (P)

University of Bourgogne, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Dijon, France.

Denis Herbreteau (D)

Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Tours), Tours, France; CHRU Tours, Department of Neuroradiology and Interventional Radiology, Tours, France.

Olivia Boccara (O)

Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Necker), University Hospital Necker-Enfants Malades, Paris, France.

Michel Wassef (M)

University Hospital of Lariboisière, AP-HP, Department of Pathology, Paris, France.

Annabel Maruani (A)

CHRU Tours, Department of Dermatology, Unit of Pediatric Dermatology, Tours, France; Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC-Tours), Tours, France; University of Tours, University of Nantes, INSERM 1246-SPHERE, Tours, France. Electronic address: annabel.maruani@univ-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH